结核性心包炎预后影响因素及综合防治策略研究进展

doi:10.19983/j.issn.2096-8493.20250031

结核与肺部疾病杂志 ›› 2025, Vol. 6 ›› Issue (4): 464-471.doi: 10.19983/j.issn.2096-8493.20250031

结核性心包炎预后影响因素及综合防治策略研究进展

谢徐萍¹, 曾晓刚²(), 李福平¹, 孙楠楠³, 余立梅⁴, 蒋其龙¹, 唐文帅¹

¹重庆医科大学附属第三医院(方大医院)心脏血管外科,重庆 401120
²重庆市公共卫生医疗救治中心胸外科,重庆 400000
³重庆市公共卫生医疗救治中心综合内科,重庆 400000
⁴重庆市南川区中医医院药剂科,重庆 408400

收稿日期:2025-02-13 出版日期:2025-08-20 发布日期:2025-08-08
通信作者: 曾晓刚,Email:zeng.xg@163.com
基金资助:
重庆市卫生健康委医学科研项目(2024WSJK059);重庆市渝北区科卫联合医学科研项目(2023YBKW11);重庆市教委科学技术研究计划项目(KJQN202200477)

Research progress on prognostic factors and comprehensive prevention and treatment strategies of tuberculous pericarditis

Xie Xuping¹, Zeng Xiaogang²(), Li Fuping¹, Sun Nannan³, Yu Limei⁴, Jiang Qilong¹, Tang Wenshuai¹

¹Department of Cardiovascular Surgery, the Third Affiliated Hospital of Chongqing Medical University (Fangda Hospital), Chongqing 401120, China
²Department of Thoracic Surgery, Chongqing Public Health Medical Treatment and Rescue Center, Chongqing 400000, China
³Department of General Internal Medicine, Chongqing Public Health Medical Treatment and Rescue Center, Chongqing 400000, China
⁴Department of Pharmacy, Nanchuan Traditional Chinese Medicine Hospital, Chongqing 408400, China

Received:2025-02-13 Online:2025-08-20 Published:2025-08-08
Contact: Zeng Xiaogang, Email: zeng.xg@163.com
Supported by:
Medical Research Projects Sponsored by the Health Commission of Chongqing Municipality(2024WSJK059);Chongqing Yubei District Kewei Joint Medical Research Project(2023YBKW11);Chongqing Municipal Education Commission Science and Technology Research Program Project(KJQN202200477)

摘要/Abstract

摘要：

结核性心包炎是一种少见但严重的结核性心脏病,具有较高的病死率和致残率,诊断和治疗均面临挑战。本文从社会生态系统理论出发,对结核性心包炎的流行、诊治现状、预后影响因素展开综述,重点探讨了多学科协作促进早期诊断和规范化诊疗、优化防治服务体系和加强信息化建设、强化患者保障和重视人才培养及科学研究等综合防治策略建议,为结核性心包炎的临床管理及相关政策优化提供了科学依据。

关键词: 心包炎,结核性, 流行病学因素, 综合预防, 综述文献(主题), 社会生态系统理论

Abstract:

Tuberculous pericarditis (TBP) is a rare yet serious tuberculous heart disease, characterized by a high mortality and morbidity rate, facing challenges in diagnosis and treatment. This article reviews the epidemiology, current diagnosis and treatment status, and prognostic factors of TBP from the perspective of social-ecological system theory. It highlights the importance of multidisciplinary collaboration in facilitating early diagnosis and standardized treatment, optimizeing prevention and care delivery systems, strengthening information technology infrastructure, improveing patient support mechanisms, and prioritizing talent training and scientific research. These comprehensive prevention and control strategy recommendations offer a robust foundation for enhancing clinical management and informing policy improvements related to TBP.

Key words: Pericarditis, tuberculous, Epidemiologic factors, Universal precautions, Review literature as topic, Social-ecological systems theory

中图分类号:

R52
R542.11

谢徐萍, 曾晓刚, 李福平, 孙楠楠, 余立梅, 蒋其龙, 唐文帅. 结核性心包炎预后影响因素及综合防治策略研究进展[J]. 结核与肺部疾病杂志, 2025, 6(4): 464-471. doi: 10.19983/j.issn.2096-8493.20250031

Xie Xuping, Zeng Xiaogang, Li Fuping, Sun Nannan, Yu Limei, Jiang Qilong, Tang Wenshuai. Research progress on prognostic factors and comprehensive prevention and treatment strategies of tuberculous pericarditis[J]. Journal of Tuberculosis and Lung Disease, 2025, 6(4): 464-471. doi: 10.19983/j.issn.2096-8493.20250031

图/表 2

参考文献 50

[1]	Wiysonge CS, Ntsekhe M, Thabane L, et al. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev, 2017, 9(9):CD000526. doi:10.1002/14651858.CD000526.pub2.
[2]	Venuti L, Condemi A, Albano C, et al. Tuberculous Pericarditis in Childhood: A Case Report and a Systematic Literature Review. Pathogens, 2024, 13(2):110. doi:10.3390/pathogens13020110.
[3]	Vaezghasemi M, Vogt T, Lindkvist M, et al. Multifaceted determinants of social-emotional problems in preschool children in Sweden: an ecological systems theory approach. SSM Popul Health, 2023, 21:101345. doi:10.1016/j.ssmph.2023.101345.
[4]	余豪如, 张玲玲, 孙妞妞, 等. 社会生态系统理论在护理领域的应用进展. 全科护理, 2023, 21(36):5064-5069. doi:10.12104/j.issn.1674-4748.2023.36.005.
[5]	孙倩, 朱文娟. 社会生态系统理论视角下老年人躯体复原力研究进展. 护理研究, 2024, 38(20):3670-3674. doi:10.12102/j.issn.1009-6493.2024.20.018.
[6]	Isiguzo G, Du Bruyn E, Howlett P, et al. Diagnosis and Management of Tuberculous Pericarditis: What Is New?. Curr Cardiol Rep, 2020, 22(1):2. doi:10.1007/s11886-020-1254-1. pmid: 31940097
[7]	Howlett P, Du Bruyn E, Morrison H, et al. The immunopathogenesis of tuberculous pericarditis. Microbes Infect, 2020, 22(4-5):172-181. doi:10.1016/j.micinf.2020.02.001. pmid: 32092538
[8]	Reuter H, Burgess LJ, Doubell AF. Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect, 2005, 133(3):393-399. doi:10.1017/s0950268804003577. pmid: 15962545
[9]	胡鑫洋, 高静韬. 世界卫生组织《2024年全球结核病报告》解读. 结核与肺部疾病杂志, 2024, 5(6):500-504. doi:10.19983/j.issn.2096-8493.2024164.
[10]	Dybowska M, Błasińska K, Gᶏtarek J, et al. Tuberculous Pericarditis-Own Experiences and Recent Recommendations. Diagnostics (Basel), 2022, 12(3):619. doi:10.3390/diagnostics12030619.
[11]	Yadav S, Shah S, Iqbal Z, et al. Pericardiectomy for Constrictive Tuberculous Pericarditis: A Systematic Review and Meta-analysis on the Etiology, Patients’ Characteristics, and the Outcomes. Cureus, 2021, 13(9):e18252. doi:10.7759/cureus.18252.
[12]	Reddy P, Kane GC, Oh JK, et al. The Evolving Etiologic and Epidemiologic Portrait of Pericardial Disease. Can J Cardiol, 2023, 39(8):1047-1058. doi:10.1016/j.cjca.2023.05.011.
[13]	Obihara NJ, Walters E, Lawrenson J, et al. Tuberculous Pericardial Effusions in Children. J Pediatric Infect Dis Soc, 2018, 7(4):346-349. doi:10.1093/jpids/pix087. pmid: 29096017
[14]	Hugo-Hamman CT, Scher H, De Moor MM. Tuberculous pericarditis in children: a review of 44 cases. Pediatr Infect Dis J, 1994, 13(1):13-18. doi:10.1097/00006454-199401000-00004. pmid: 8170726
[15]	马玙, 朱莉贞, 潘毓萱. 结核病病. 北京: 人民卫生出版社, 2006.
[16]	王永生, 周航, 刘蔺, 等. 结核感染T细胞斑点试验在结核性心包炎诊断中的应用. 四川医学, 2013, 34(2):159-160. doi:10.16252/j.cnki.issn1004-0501-2013.02.021.
[17]	Ebrahimzadeh A, Pagheh AS, Mousavi T, et al. Serosal membrane tuberculosis in Iran: A comprehensive review of evidences. J Clin Tuberc Other Mycobact Dis, 2023, 31:100354. doi:10.1016/j.jctube.2023.100354.
[18]	Chang SA. Tuberculous and Infectious Pericarditis. Cardiol Clin, 2017, 35(4):615-622. doi:10.1016/j.ccl.2017.07.013.
[19]	Liebenberg JJ, Dold CJ, Olivier LR. A prospective investigation into the effect of colchicine on tuberculous pericarditis. Cardiovasc J Afr, 2016, 27(6):350-355. doi:10.5830/CVJA-2016-035. pmid: 27965998
[20]	Naicker K, Ntsekhe M. Tuberculous pericardial disease: a focused update on diagnosis, therapy and prevention of complications. Cardiovasc Diagn Ther, 2020, 10(2):289-295. doi:10.21037/cdt.2019.09.20.
[21]	Mayosi BM, Ntsekhe M, Bosch J, et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med, 2014, 371(12):1121-1130. doi:10.1056/NEJMoa1407380.
[22]	Adler Y, Charron P, Imazio M et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 2015, 36(42):2921-2964. doi:10.1093/eurheartj/ehv318.
[23]	Tzani A, Doulamis IP, Tzoumas A, et al. Meta-Analysis of Population Characteristics and Outcomes of Patients Undergoing Pericardiectomy for Constrictive Pericarditis. Am J Cardiol, 2021, 146: 120-127. doi:10.1016/j.amjcard.2021.01.033. pmid: 33539860
[24]	Oruc MA, Ozdemir S, Oztomurcuk D. Characteristics of tuberculosis-related deaths and risk factors: a retrospective cohort study in Samsun province of Turkey. Postgrad Med, 2022, 134(2): 217-223. doi:10.1080/00325481.2022.2029106. pmid: 35048749
[25]	Tegegne BS, Mengesha MM, Teferra AA, et al. Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis. Syst Rev, 2018, 7(1): 161. doi:10.1186/s13643-018-0828-0. pmid: 30322409
[26]	Steigler P, Chhiba M, Francis V, et al. T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis. Vaccine X, 2022, 11:100177. doi:10.1016/j.jvacx.2022.100177.
[27]	Ramasamy V, Mayosi BM, Sturrock ED, et al. Established and novel pathophysiological mechanisms of pericardial injury and constrictive pericarditis. World J Cardiol, 2018, 10(9):87-96. doi:10.4330/wjc.v10.i9.87. pmid: 30344956
[28]	陈杰, 罗勇, 袁武, 等. 112例结核性缩窄性心包炎外科治疗的临床分析. 四川医学, 2024, 45(10):1057-1060. doi:10.16252/j.cnki.issn1004-0501-2024.10.001.
[29]	Busch C, Penov K, Amorim PA, et al. Risk factors for mortality after pericardiectomy for chronic constrictive pericarditis in a large single-centre cohort. Eur J Cardiothorac Surg, 2015, 48(6): e110-e116. doi:10.1093/ejcts/ezv322.
[30]	谭隽怡, 向明确, 李天驹, 等. 营养因素与结核病患者预后相关研究进展. 中国感染与化疗杂志, 2024, 24(3): 366-370. doi:10.16718/j.1009-7708.2024.03.019.
[31]	陈志, 梁建琴. 结核病重症患者营养评估及营养支持治疗专家共识. 中国防痨杂志, 2022, 44(5):421-432. doi:10.19982/j.issn.1000-6621.20220041.
[32]	丁芹, 陈薇, 张胜康, 等. 肺外结核患者的营养状况调查及影响因素分析. 中国防痨杂志, 2023, 45(9):839-844. doi:10.19982/j.issn.1000-6621.20230221.
[33]	高雅, 吴桂辉, 吴世幸, 等. 258例住院肺外结核病患者营养状况及其相关风险因素分析. 临床肺科杂志, 2023, 28(2):167-171. doi:10.3969/j.issn.1009-6663.2023.02.002.
[34]	杨红雨, 刘巧林, 康雄, 等. 结核病与AIDS共病预后影响因素及综合防治策略研究进展. 结核与肺部疾病杂志, 2024, 5(6):590-596. doi:10.19983/j.issn.2096-8493.2024109.
[35]	孙青峰, 李浩然, 逄宇, 等. 结核病与抑郁症共病的研究进展. 中国防痨杂志, 2024, 46(1):106-111. doi:10.19982/j.issn.1000-6621.20230381.
[36]	夏金红, 朱爱珍, 金婷婷, 等. 综合社会支持对老年结核病患者的生活质量影响分析. 中国防痨杂志, 2024, 46(S1):210-212.
[37]	阮淑金, 曾坚, 陈敬芳, 等. 结核病治疗依从性状况、影响因素及干预措施研究进展. 结核与肺部疾病杂志, 2023, 4(5):419-424. doi:10.19983/j.issn.2096-8493.20230076.
[38]	陈伟, 孙慧娟, 赵雁林. 新时期我国结核病防治服务体系建设及展望. 结核与肺部疾病杂志, 2024, 5(2): 95-100. doi:10.19983/j.issn.2096-8493.2024025.
[39]	刘二勇, 李玉红, 周林, 等. 统筹兼顾:肺外结核应纳入防治规划. 中国防痨杂志, 2021, 43(5): 428-431. doi:10.3969/j.issn.1000-6621.2021.05.003.
[40]	王立群, 孙国琴. 医保背景下耐药结核病经济负担的分析. 中国防痨杂志, 2024, 46(S1):313-315.
[41]	曾谊, 兰学立, 路希维. 重视结核病相关疾病的整合医学管理. 中国防痨杂志, 2024, 46(7): 735-738. doi:10.19982/j.issn.1000-6621.20240173.
[42]	梁晨, 唐神结, 林明贵. 结核病综合治疗研究进展. 结核与肺部疾病杂志, 2024, 5(1):70-80. doi:10.19983/j.issn.2096-8493.20230112.
[43]	周文雍, 文泽轩, 高梦贤, 等. 全国结核病免费医疗策略实施的效果和影响预测. 中国防痨杂志, 2023, 45(9):845-856. doi:10.19982/j.issn.1000-6621.20230143.
[44]	刘翠华, 任小波, 汪静, 等. 科技助力结核病防控:现状、进展与对策. 中国科学院院刊, 2022, 37(1):112-122. doi:10.16418/j.issn.1000-3045.20211116002.
[45]	徐彩红, 赵雁林. 构建智慧化网络助力结核病防治. 中国防痨杂志, 2022, 44(3):215-218. doi:10.19982/j.issn.1000-6621.20210724.
[46]	陈伟, 李雪, 刘小秋, 等. 《全国结核病防治规划(2024—2030年)》解读. 中国防痨杂志, 2024, 46(12):1-17. doi:10.19982/j.issn.1000-6621.20240585.
[47]	宋毅杰, 徐修远, 王宁, 等. 肺结核外科数据库系统与区域信息共享平台构建. 中国胸心血管外科临床杂志, 2023, 30(12):1749-1756. doi:10.7507/1007-4848.202307005.
[48]	王倩, 郭肖岩, 李海涛, 等. 山东省结核病防治综合管理智慧化平台构建与应用. 中国公共卫生, 2024, 40(4):516-520. doi:10.11847/zgggws1143749.
[49]	赵亚芳, 蔡青山. 人工智能技术在结核病领域应用现状. 浙江中西医结合杂志, 2024, 34(1):88-91. doi:10.3969/j.issn.1005-4561.2024.01.021.
[50]	李汶翰, 杨静, 李春华. 人工智能在肺结核影像诊断及耐药性预测中的研究进展. 中国防痨杂志, 2024, 46(9):1098-1103. doi:10.19982/j.issn.1000-6621.20240123.

结核性心包炎预后影响因素及综合防治策略研究进展

Research progress on prognostic factors and comprehensive prevention and treatment strategies of tuberculous pericarditis

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 2

参考文献 50

相关文章 15

编辑推荐

Metrics

本文评价

友情链接

[1]	王宁, 王宝华. 全球肺癌负担、防治现况与展望[J]. 结核与肺部疾病杂志, 2025, 6(3): 256-260.
[2]	钱桂兰, 王琳. 慢性阻塞性肺疾病患者家属照顾负担的研究进展[J]. 结核与肺部疾病杂志, 2025, 6(3): 343-347.
[3]	杨艳, 董文, 陈建军, 张玉. 2014—2023年湖北省十堰市竹溪县肺结核流行特征分析[J]. 结核与肺部疾病杂志, 2025, 6(1): 40-45.
[4]	杨舒琪, 李锋. 程序性死亡受体1/程序性死亡-配体1抑制剂在结核病研究中的进展[J]. 结核与肺部疾病杂志, 2025, 6(1): 94-101.
[5]	范伟芳, 黄金鹏, 姚丽伟. 结核后肺疾病患者肺康复护理的研究进展[J]. 结核与肺部疾病杂志, 2024, 5(6): 560-566.
[6]	孟婷, 陈敬芳, 邓国防, 林奕, 阮淑金, 刘琳琳, 李孟君. 结核病患者心理脆弱及焦虑抑郁状态相关研究进展[J]. 结核与肺部疾病杂志, 2024, 5(6): 583-589.
[7]	赵菲, 詹璐. miR-451a调控TLR4信号通路在结核病发病中的研究进展[J]. 结核与肺部疾病杂志, 2024, 5(5): 484-488.
[8]	何繁漪, 陆霓虹, 杜映荣. 结核病与COVID-19相互作用的研究进展[J]. 结核与肺部疾病杂志, 2024, 5(4): 345-351.
[9]	赵君, 杨红雨, 康雄. 肺结核患者病耻感影响因素及干预策略研究进展[J]. 结核与肺部疾病杂志, 2024, 5(4): 364-369.
[10]	屈春瑾, 彭佳怡, 刘鈊逸, 肖冠琛, 顾芬, 李楠楠. 慢性阻塞性肺疾病患者延续性护理研究进展[J]. 结核与肺部疾病杂志, 2024, 5(3): 254-259.
[11]	张亚敬, 任丽君, 王明良, 姜影, 周琳, 唐桂琴. 2012—2022年北京市石景山区肺结核流行特征分析[J]. 结核与肺部疾病杂志, 2024, 5(2): 158-163.
[12]	闫彦峰, 漆文霞, 崔永慧, 魏彩虹. 长链非编码RNA在慢性阻塞性肺疾病中的表达及其作用研究进展[J]. 结核与肺部疾病杂志, 2024, 5(2): 172-178.
[13]	朋毛措, 谢俊刚. 免疫细胞在慢性阻塞性肺疾病并发心血管疾病中的研究进展[J]. 结核与肺部疾病杂志, 2024, 5(2): 179-185.
[14]	曹红, 钱冰, 吴金菊. 学校结核病疫情现状及防控工作研究进展[J]. 结核与肺部疾病杂志, 2024, 5(1): 88-92.
[15]	戴中上, 钟严俊, 陈燕. 慢性阻塞性肺疾病合并支气管扩张症的研究进展[J]. 结核与肺部疾病杂志, 2023, 4(6): 499-505.